HCM screening registry for people with flagged ECGs
Part of Heart & circulation clinical trials.
This registry study collects information from people whose ECG tests were flagged by a special computer program as possibly showing hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. It helps doctors learn more about how well the program works and how it affects patient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a resting 12-lead ECG that was flagged by the Viz HCM system as possibly showing HCM.
- You are in one of these groups: newly diagnosed with HCM, previously diagnosed, suspected but not confirmed, unlikely HCM, or your alert was not reviewed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health records, heart ultrasound (echo), MRI images, and optional DNA testing for people with hypertrophic cardiomyopathy (HCM). It aims to build a large database to better understand HCM and support future research and care.
This study tracks people with hypertrophic cardiomyopathy, a heart muscle disease, to learn more about the condition and improve care. It does not test a new treatment but collects health information over time.
This study uses artificial intelligence to analyze ECGs and echoes from people with hypertrophic cardiomyopathy (HCM) to improve how the disease is detected and managed. If you have HCM with a thickened heart wall and available heart tests, you may help train the AI.
This program builds a registry of people diagnosed with hypertrophic cardiomyopathy and their family members. By collecting health information over time, researchers hope to better understand the condition and improve care.
This study creates a registry (a detailed record) for people with hypertrophic cardiomyopathy, a condition where the heart muscle is thicker than normal. It aims to learn more about the condition over time.
This registry collects information about people with hypertrophic cardiomyopathy (HCM) to better understand the condition and improve care. It is for patients who have a confirmed HCM diagnosis not caused by other issues.
Hear when a new Hypertrophic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.